PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
![Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/43cc48d1-0be0-403a-9246-02a545426442/gr1.gif)
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
![PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bebf64d9eed1781065a2c153404d554135ca30a3/3-Table1-1.png)
PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar
![Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)](https://bmjopen.bmj.com/content/bmjopen/5/12/e009562/F1.large.jpg)
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
![Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/885_726415/Slide1.jpg)
Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD
![Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol](https://bmjopen.bmj.com/content/bmjopen/3/7/e002902/F1.large.jpg)
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
![Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK546770/bin/clapp7f1.jpg)
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
![Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-60644-9/MediaObjects/41598_2020_60644_Fig1_HTML.png)
Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports
![A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. | Semantic Scholar A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bec56b2efc7a2d4808dc0031e49b6c04d6f95280/25-Figure1-1.png)
A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. | Semantic Scholar
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
![How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download](https://images.slideplayer.com/23/6590870/slides/slide_3.jpg)
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
PLOS ONE: Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials
![An Open-Label, Pragmatic, Randomized Controlled Clinical Trial to Evaluate the Comparative Effectiveness of Daptomycin Versus Vancomycin for the Treatment of Complicated Skin and Skin Structure Infection An Open-Label, Pragmatic, Randomized Controlled Clinical Trial to Evaluate the Comparative Effectiveness of Daptomycin Versus Vancomycin for the Treatment of Complicated Skin and Skin Structure Infection](https://repositories.lib.utexas.edu/bitstream/handle/2152/43336/2015_11_Kauf.pdf.jpg?sequence=4&isAllowed=y)
An Open-Label, Pragmatic, Randomized Controlled Clinical Trial to Evaluate the Comparative Effectiveness of Daptomycin Versus Vancomycin for the Treatment of Complicated Skin and Skin Structure Infection
![Oral Azithromycin vs Doxycycline in MGD: A Randomized Double-masked Open-label Clinical Trial | TFOS blog Oral Azithromycin vs Doxycycline in MGD: A Randomized Double-masked Open-label Clinical Trial | TFOS blog](http://www.thedryeyereview.com/wp-content/uploads/2015/01/bigstock-picture-of-doctor-hands-giving-46645024-300x223.jpg)